Longevity & Cellular

For cellular-energy and longevity research in 2026, the three most-compared in-vitro tools are the NAD+ research pen, the MOTS-c peptide pen and the SS-31 peptide pen. Each targets a distinct biological mechanism: NAD+ is a redox coenzyme studied in sirtuin and PARP signalling pathways, whereas MOTS-c and SS-31 are mitochondrially associated peptides examined for roles in AMPK activation and cardiolipin binding respectively [1]. All materials discussed on this page are supplied for laboratory and in-vitro research; not for human or veterinary use.

Current price and availability for all three are shown on the live product pages, which carry the dated commercial figures.

Veyvora’s longevity research catalogue for 2026 contains three distinct pen-format tools — the NAD+ research pen, the MOTS-c peptide pen and the SS-31 peptide pen. Each occupies a separate mechanistic category and is supplied for in-vitro laboratory research.

NAD+ Research Pen

NAD+ (nicotinamide adenine dinucleotide) is a pyridine dinucleotide coenzyme studied in redox biology, sirtuin activation and PARP-mediated DNA-repair signalling. Research interest centres on coenzyme pool size and the enzymes that regulate it, NAMPT, NMNAT and CD38, rather than on peptide–membrane interactions. The NAD+ 1000 research pen is listed in the Veyvora 2026 catalogue as a 3 mL pen-format device delivering 300 clicks at 133 µg per click, supplied with a dosing card and 31G 6 mm pen needles. Current availability and price are shown on the product page.

MOTS-c and SS-31 Peptide Pens

MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA, studied for its activity on AMPK and folate–AICAR signalling pathways [1]. SS-31 (elamipretide) is a synthetic tetrapeptide examined for its capacity to associate with cardiolipin on the inner mitochondrial membrane [1]. Each peptide has its own mechanistic category, distinct from NAD+ coenzyme biology, and current peer-reviewed literature treats the three entities as distinct research tools. For the combined research context of these two mitochondrial peptides, MOTS-c + SS-31 research explained provides the relevant background.

Veyvora states that each batch across all three pen formats is tested by two independent laboratories using HPLC, mass spectrometry and endotoxin assay, with a reported purity threshold above 98% (Veyvora quality documentation, 2026). Researchers interpreting batch certificates of analysis can consult how to read HPLC purity for what the purity field reports.

The three research tools covered in this guide operate at different levels of the evidence hierarchy. NAD+ coenzyme biology is supported by extensive mechanistic and preclinical literature addressing NAMPT, NMNAT and CD38 pathways, sirtuin activation and PARP signalling. MOTS-c and SS-31 research sits predominantly at the peptide-mechanism and early preclinical stage, with MOTS-c characterised through AMPK and folate–AICAR pathway studies and SS-31 through cardiolipin-binding assays on the inner mitochondrial membrane [1].

What the Evidence Supports

Mechanistic findings from cell-free or cell-based assays establish pathway interactions under controlled in-vitro conditions, and preclinical rodent data, where it exists for any of these entities, extend those findings into a living system. No single peer-reviewed paper published between 2024 and 2026 treats NAD+, MOTS-c and SS-31 as interchangeable longevity tools or presents a head-to-head in-vitro methods comparison across all three [1]. Each entity is mechanistically distinct, with its own assay design.

All materials available through the Veyvora research peptide catalogue are supplied for in-vitro laboratory research.

Researchers who have reviewed the procurement and verification criteria on this page confirm batch identity against the certificate of analysis before any in-vitro work begins. The pages below address the distinct tasks that follow from that decision.

Analytical Verification

Before accepting a consignment, confirm that the reported HPLC purity meets the stated threshold and that the molecular weight matches the theoretical value for the entity ordered. How to read HPLC purity explains the analytical method and what each field in a purity report represents. Once the CoA is in hand, verify your batch against its CoA provides a structured checklist for cross-referencing batch number, identity, purity and stability data.

Mechanistic and Comparative Context

For researchers deciding between the two mitochondrial peptide tools, the MOTS-c and SS-31 comparison sets out format and specification differences in consistent terms. The mechanistic basis for studying MOTS-c and SS-31 together is covered in MOTS-c + SS-31 research explained, which addresses the distinct signalling pathways, AMPK/folate–AICAR for MOTS-c and cardiolipin binding for SS-31, alongside NAD+ coenzyme biology as a separate category. For the coenzyme itself, NAD+ research explained provides the relevant mechanistic background.